The Drug Information Association (DIA) is a global professional organization that supports life sciences development through education, collaboration, and regulatory science engagement.
DIA convenes regulators, sponsors, CROs, and academic stakeholders to share best practices in clinical development and pharmacovigilance. Its conferences and training programs often address evolving guidance on trial design, safety reporting, and data standards. DIA resources help organizations align operational practices with regulatory expectations across regions. Participation supports innovation while strengthening compliance maturity in development programs.